| |
| |
|
| Insider
Information: |
Kumar Neil |
| Relationship: |
Director |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
4,897,443 |
|
|
Indirect Shares
|
31,586,701 |
|
|
| Direct
Value |
$136,834,557 |
|
|
|
Indirect Value
|
$3,059,486,897 |
|
|
| Total
Shares |
36,484,144 |
|
|
| Total
Value |
$3,196,321,454 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 481.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eidos Therapeutics, Inc. |
EIDX |
Chief Executive Office... |
2018-06-22 |
0 |
2019-07-03 |
24,575,501 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-05-16 |
4,897,443 |
2024-05-16 |
2,008,408 |
Premium* |
|
|
Lianbio |
LIAN |
Director |
|
0 |
2021-10-29 |
5,002,792 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
72 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LIAN |
Lianbio |
Director |
– • – |
2021-10-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
5,002,792 |
|
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-04-03 |
4 |
AS |
$25.09 |
$7,528 |
I/I |
(300) |
2,567,177 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-08-16 |
4 |
D |
$28.53 |
$50,612 |
D/D |
(1,774) |
4,689,080 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-11-16 |
4 |
D |
$44.33 |
$78,641 |
D/D |
(1,774) |
4,692,435 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-04-07 |
4 |
AS |
$25.48 |
$45,983 |
I/I |
(1,805) |
2,565,372 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-02-16 |
4 |
D |
$64.98 |
$138,992 |
D/D |
(2,139) |
4,695,425 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-02-16 |
4 |
D |
$8.84 |
$27,271 |
D/D |
(3,085) |
4,727,243 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-08-16 |
4 |
D |
$49.48 |
$184,560 |
D/D |
(3,730) |
4,719,011 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-11-16 |
4 |
D |
$47.25 |
$176,243 |
D/D |
(3,730) |
4,722,804 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-05-16 |
4 |
D |
$53.66 |
$200,205 |
D/D |
(3,731) |
4,715,218 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,690,854 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,694,209 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,129 |
4,697,564 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-06-03 |
4 |
AS |
$30.05 |
$178,173 |
I/I |
(5,930) |
2,319,442 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,722,741 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,523 |
4,726,534 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,718,949 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,524 |
4,730,328 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-06-08 |
4 |
AS |
$30.01 |
$318,125 |
I/I |
(10,600) |
2,308,842 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-08-04 |
4 |
AS |
$26.70 |
$376,760 |
I/I |
(13,943) |
2,085,372 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-04-02 |
4 |
AS |
$25.04 |
$395,103 |
I/I |
(15,778) |
2,567,477 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2021-02-17 |
4 |
A |
$62.50 |
$1,000,000 |
D/D |
16,000 |
4,711,425 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2020-03-03 |
4 |
AS |
$31.76 |
$647,148 |
I/I |
(20,047) |
2,645,372 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2022-05-16 |
4 |
D |
$6.74 |
$160,136 |
D/D |
(23,759) |
4,772,189 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
CEO and President |
• • – |
2023-02-16 |
4 |
D |
$12.64 |
$302,197 |
D/D |
(23,908) |
4,857,995 |
0 |
- |
|
72 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
